Price T Rowe Associates Inc Tenaya Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 67,582 shares of TNYA stock, worth $51,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,582

Previous 89,570 24.55%

Holding current value

$51,362

Previous $52,000 19.23%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.39 - $0.69 $8,575 - $15,171	-21,988 Reduced 24.55%	67,582 $42,000
Q1 2025 May 14, 2025	SELL	$0.44 - $1.52 $20,532 - $70,929	-46,664 Reduced 34.25%	89,570 $52,000
Q4 2024 Feb 14, 2025	SELL	$1.23 - $3.78 $3.56 Million - $10.9 Million	-2,892,201 Reduced 95.5%	136,234 $196,000
Q3 2024 Nov 14, 2024	SELL	$1.93 - $3.99 $936,607 - $1.94 Million	-485,289 Reduced 13.81%	3,028,435 $5.85 Million
Q2 2024 Aug 14, 2024	BUY	$2.72 - $4.99 $454,789 - $834,337	167,202 Added 5.0%	3,513,724 $10.9 Million
Q1 2024 May 15, 2024	SELL	$2.88 - $6.8 $3.45 Million - $8.15 Million	-1,198,021 Reduced 26.36%	3,346,522 $17.5 Million
Q4 2023 Feb 14, 2024	BUY	$1.73 - $3.39 $120,022 - $235,188	69,377 Added 1.55%	4,544,543 $14.7 Million
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.65 $14,088 - $31,216	5,525 Added 0.12%	4,475,166 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$2.64 - $7.64 $218,745 - $633,035	82,858 Added 1.89%	4,469,641 $26.2 Million
Q1 2023 May 15, 2023	SELL	$1.92 - $3.59 $164,004 - $306,654	-85,419 Reduced 1.91%	4,386,783 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.19 $3.96 Million - $7.52 Million	2,357,950 Added 111.53%	4,472,202 $8.99 Million
Q3 2022 Nov 14, 2022	SELL	$2.9 - $5.88 $3.63 Million - $7.36 Million	-1,252,528 Reduced 37.2%	2,114,252 $6.13 Million
Q2 2022 Aug 15, 2022	BUY	$5.01 - $14.12 $1.68 Million - $4.74 Million	335,378 Added 11.06%	3,366,780 $19 Million
Q1 2022 May 16, 2022	BUY	$9.41 - $19.3 $356,629 - $731,450	37,899 Added 1.27%	3,031,402 $35.7 Million
Q4 2021 Feb 14, 2022	BUY	$18.41 - $29.58 $4.06 Million - $6.52 Million	220,394 Added 7.95%	2,993,503 $55.6 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $26.66 $42.6 Million - $73.9 Million	2,773,109 New	2,773,109 $56 Million

Others Institutions Holding TNYA

# of Institutions

Shares Held

36.6M

Call Options Held

91.4K

Put Options Held

50.3K

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $31.4M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Tenaya Therapeutics, Inc. Transaction History